Regenacip 200MIU Injection: Effective Solution for Medical Needs

Description:

• Contains mesenchymal stromal cells derived from the human bone marrow of unrelated healthy adult donors.
• Treats critical limb ischemia caused by atherosclerotic peripheral artery disease (PAD).
• PAD is a disease in which the blood vessels that supply blood from the heart to the legs get blocked due to fat deposits, and the blood supply to limbs is insufficient.

Uses:

• Treats critical limb ischemia due to atherosclerotic peripheral artery disease (PAD).

Therapeutic Effects:

• Helps develop new blood vessel cells.
• Improves blood supply to the affected limb or its parts.

Interaction with Other Drugs:

• Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products you take or have taken before the treatment.
• Certain medications may interact with Regenacip 200MIU injection and cause undesirable side effects.

Storage and Administration:

• Regenacip 200MIU Injection is directly supplied to the treating hospital.
• The cells are supplied in a frozen condition in a cryobag and shipped in a cryoshipper at a temperature between – 185°C to – 196°C.
• Regenacip 200MIU Injection is given only in a hospital setup by a trained healthcare provider.
• Administered intramuscularly: adults in the arm, children in the thigh.
• Dosage decided by the doctor based on age, body weight, and physical circumstances.

Safety Advices:

• Pregnancy: inform your doctor if you are pregnant, think you may get pregnant, or are planning to get pregnant before taking Regenacip 200MIU Injection.
• Breastfeeding: inform your doctor if you are breastfeeding before taking Regenacip 200MIU Injection.
• Lungs: it is unknown whether it is safe to take Regenacip 200MIU Injection for lung patients.
• Liver: it is unknown whether it is safe to take Regenacip 200MIU Injection for liver patients.
• Alcohol: it is not recommended to take alcohol while on treatment with Regenacip 200MIU injection.
• Driving: it is unknown whether Regenacip 200MIU injection affects the driving ability.

Side Effects:

• Common side effects include fever, nausea, vomiting, pain, and infection at the injection site.

Word of Advice:

• Maintain a comprehensive record of your symptoms, side effects, and any changes in your health throughout the Regenacip 200MIU Injection treatment.
• Stay well-hydrated, engage in light physical activities as advised, and prioritize a balanced diet to support the overall effectiveness of the therapy.

FAQs:

1. Can I participate in strenuous physical activities during the treatment with Regenacip 200MIU Injection?
   • It's advisable to consult your healthcare provider before engaging in strenuous activities. Light exercises may be recommended based on your individual circumstances.
2. What measures can I take to manage Regenacip 200MIU Injection site pain or infection?
   • Follow proper hygiene practices at the injection site. If you experience persistent pain or signs of infection, promptly inform your healthcare provider.
3. Are there any specific dietary restrictions during Regenacip 200MIU Injection therapy?
   • While there might not be strict restrictions, maintaining a nutritious diet can positively impact the treatment outcome. Consult your doctor for personalized dietary advice.
4. How often will I need to undergo Regenacip 200MIU Injection?
   • The frequency of injections will be determined by your healthcare provider based on your response to the treatment. Follow the prescribed schedule diligently.
5. Can Regenacip 200MIU Injection treatment interact with herbal supplements?
   • Inform your doctor about any herbal supplements you are taking. Some supplements may interact with Regenacip 200MIU Injection, and your doctor can provide guidance accordingly.

Fact Box:

• Molecule Name: Mesenchymal stroma cells
• Therapeutic class: Regenerative agents
• Pharmacological class: Multipotent stem cells
• Indications: Treats critical limb ischemia due to atherosclerotic peripheral artery disease (PAD)

Tags: regenacip, injection, medical-drug, pharmaceutical, health-products, medicine, 200miu